Social media voices on the treatment of skin psoriasis with biologics
Social media is an outlet for patients to share medical experiences with a large audience. However, the impact of such content on individual patient treatment decisions has yet to be fully explored. We characterized patient experiences posted on social media surrounding biologic use for skin psorias...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-11-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09546634.2022.2126276 |
| _version_ | 1797683516331261952 |
|---|---|
| author | Melissa A. Nickles Roger N. Haber |
| author_facet | Melissa A. Nickles Roger N. Haber |
| author_sort | Melissa A. Nickles |
| collection | DOAJ |
| description | Social media is an outlet for patients to share medical experiences with a large audience. However, the impact of such content on individual patient treatment decisions has yet to be fully explored. We characterized patient experiences posted on social media surrounding biologic use for skin psoriasis. We analyzed content from YouTube, Instagram, and TikTok and identified patient experiences with a variety of biologics, most commonly Humira (20.7%), Cosentyx (14.0%), and Stelara (14.0%). The biologic was described as burdensome in about half of all videos/posts (46.4%), and the most commonly cited reasons included adverse effects or abnormal blood tests (12.8%), cost or insurance issues (11.7%), lack or loss of efficacy (11.7%), and pain with injection or injection site reaction (11.7%). Nevertheless, the majority (60.9%) of videos/posts reported an overall positive experience with a biologic for their skin psoriasis, which may inspire reluctant patients to try a biologic recommended by their physician. |
| first_indexed | 2024-03-12T00:15:34Z |
| format | Article |
| id | doaj.art-ff718f9558a44c1baef4bc0080215a99 |
| institution | Directory Open Access Journal |
| issn | 0954-6634 1471-1753 |
| language | English |
| last_indexed | 2024-03-12T00:15:34Z |
| publishDate | 2022-11-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Dermatological Treatment |
| spelling | doaj.art-ff718f9558a44c1baef4bc0080215a992023-09-15T14:28:52ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532022-11-013383208320910.1080/09546634.2022.21262762126276Social media voices on the treatment of skin psoriasis with biologicsMelissa A. Nickles0Roger N. Haber1Department of Dermatology, University of Illinois at Chicago College of MedicineDepartment of Dermatology, University of Illinois at Chicago College of MedicineSocial media is an outlet for patients to share medical experiences with a large audience. However, the impact of such content on individual patient treatment decisions has yet to be fully explored. We characterized patient experiences posted on social media surrounding biologic use for skin psoriasis. We analyzed content from YouTube, Instagram, and TikTok and identified patient experiences with a variety of biologics, most commonly Humira (20.7%), Cosentyx (14.0%), and Stelara (14.0%). The biologic was described as burdensome in about half of all videos/posts (46.4%), and the most commonly cited reasons included adverse effects or abnormal blood tests (12.8%), cost or insurance issues (11.7%), lack or loss of efficacy (11.7%), and pain with injection or injection site reaction (11.7%). Nevertheless, the majority (60.9%) of videos/posts reported an overall positive experience with a biologic for their skin psoriasis, which may inspire reluctant patients to try a biologic recommended by their physician.http://dx.doi.org/10.1080/09546634.2022.2126276social mediapsoriasis biologicspatient perceptionspatient attitudes |
| spellingShingle | Melissa A. Nickles Roger N. Haber Social media voices on the treatment of skin psoriasis with biologics Journal of Dermatological Treatment social media psoriasis biologics patient perceptions patient attitudes |
| title | Social media voices on the treatment of skin psoriasis with biologics |
| title_full | Social media voices on the treatment of skin psoriasis with biologics |
| title_fullStr | Social media voices on the treatment of skin psoriasis with biologics |
| title_full_unstemmed | Social media voices on the treatment of skin psoriasis with biologics |
| title_short | Social media voices on the treatment of skin psoriasis with biologics |
| title_sort | social media voices on the treatment of skin psoriasis with biologics |
| topic | social media psoriasis biologics patient perceptions patient attitudes |
| url | http://dx.doi.org/10.1080/09546634.2022.2126276 |
| work_keys_str_mv | AT melissaanickles socialmediavoicesonthetreatmentofskinpsoriasiswithbiologics AT rogernhaber socialmediavoicesonthetreatmentofskinpsoriasiswithbiologics |